GlassScriptPhysician profile
Aphrodite Henderson
NPI 1861471450
$4,620.64
in general payments reported to CMS, 2019-2025
7 companies · $36.13 in 2025
The $36.13 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,685 · 2021: $264 · 2022: $74.53 · 2023: $534 · 2024: $27.15 · 2025: $36.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $378 · Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $378.18 |
| Food and Beverage | $219.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,948.39 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $534.44 | 2023 | Venclose Maven Catheter |
| Zimmer Biomet Holdings, INC. | $74.53 | 2022 | |
| Hologic Sales and Service, LLC | $18.99 | 2025 | Magseed, Sentimag, Magtrace |
| Solventum Corporation | $17.14 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Braintree Laboratories, INC. | $15.29 | 2024 | Suflave |
| Endomagnetics LTD | $11.86 | 2024 | Magseed, Magtrace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aphrodite Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.